MJFF Therapeutic Pipeline Program
Call- and stage-specific grant for Parkinson's therapeutic development; no universal award range · The Michael J. Fox Foundation · rolling applications
MJFF Therapeutic Pipeline Program is a grant programme from The Michael J. Fox Foundation for Biotechnology and pharmaceutical companies and research organisations worldwide developing Parkinson's disease therapeutics or tools under an open call Current lifecycle: unknown. Real economics: Call- and stage-specific grant for Parkinson's therapeutic development; no universal award range.
Tier 3foundationglobalhealthparkinsons
ApplyOfficial siteOpen in the live directory
Key facts
| Funder | The Michael J. Fox Foundation |
| Amount | Call- and stage-specific grant for Parkinson's therapeutic development; no universal award range |
| Deadline | Rolling — apply anytime |
| Decision time | No universal application-to-decision interval is published for the currently verified route. |
| Eligibility | An industry or research team must fit a live MJFF call and show a credible disease-relevance, development and translation plan. |
| Restrictions | Awardees provide milestone, scientific, financial and portfolio updates under the project agreement. Restricted to the selected Parkinson's research or therapeutic-development scope. |
| Status | rolling |
Always confirm on the official page before applying — dates and terms change.
Application process
- Choose a live funding opportunity
- Submit a pre-proposal or full proposal as specified
- Complete scientific and portfolio review
- Respond to diligence
- Contract and deliver milestones
Background
The Michael J. Fox Foundation operates MJFF Therapeutic Pipeline Program. This pass separates direct cash, repayable finance, credits, incentives and umbrella programs so later ranking does not compare unlike instruments. MJFF operates a global therapeutic and research-tools funding portfolio for Parkinson's disease.
How the application really works
Choose a live funding opportunity → Submit a pre-proposal or full proposal as specified → Complete scientific and portfolio review → Respond to diligence → Contract and deliver milestones
Tips
- Show direct fit with Parkinson's disease therapeutics.
- Show direct fit with research tools.
Watch out for
- Current lifecycle is unknown.
- Awardees provide milestone, scientific, financial and portfolio updates under the project agreement.
- Restricted to the selected Parkinson's research or therapeutic-development scope.
Track record
- MJFF operates a global therapeutic and research-tools funding portfolio for Parkinson's disease.
No comparable current application denominator, award count and acceptance rate are published.
Frequently asked questions
- Is this actionable now?
- unknown. MJFF publishes topic-specific funding opportunities with separate deadlines and stages.
- What is the real economic value?
- Call- and stage-specific grant for Parkinson's therapeutic development; no universal award range
- Who is eligible?
- An industry or research team must fit a live MJFF call and show a credible disease-relevance, development and translation plan.
- How does selection work?
- Choose a live funding opportunity; Submit a pre-proposal or full proposal as specified; Complete scientific and portfolio review; Respond to diligence; Contract and deliver milestones. No universal application-to-decision interval is published for the currently verified route.
- What burden and restrictions apply?
- Awardees provide milestone, scientific, financial and portfolio updates under the project agreement. Restricted to the selected Parkinson's research or therapeutic-development scope.
- What evidence exists?
- MJFF operates a global therapeutic and research-tools funding portfolio for Parkinson's disease. No comparable current application denominator, award count and acceptance rate are published.
Related grants
Sources
- www.michaeljfox.org/funding-opportunities — Official current calls, applicants and application route (checked 2026-08-10)